Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world†but would also be a massive growth engine for the country.COVID-19 could give momentum to Indian healthcare industry: HUL CMD Sanjiv Mehta
Making a case for restarting manufacturing of APIs Active Pharmaceutical Ingredients), Mehta said this would not only help India become the “affordable healthcare capital of the world†but would also be a massive growth engine for the country.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment